22 06 28 Slovenia

CS MEDICA has signed a distributor agreement with Slovenia based NaturaMedica

CS MEDICA (”CS MEDICA” or the ”Company”) announces today that the Company has signed an distributor agreement with NaturaMedica. The agreement covers the territory of Slovenia and includes 4 of CS MEDICA’s medical device products under the CANNASEN brand.  The order amounts to 20,700 units, corresponding to DKK 0,9 million in revenue which will be distributed over a 3.5-year period.

Lone Henriksen, CEO of CS MEDICA, pronounces:

I am very glad to announce that CS MEDICA continues to expand on the European market. The Agreement with NaturaMedica demonstrates that our products are wanted and gives us a broader customer base in Europe. We hope that this agreement will spark more interest around Europe as we continue our expansion.”

CS MEDICA reveals today that the Company has signed a distributor agreement with NaturaMedica. NaturaMedica is a company with a great network and extensive market know-how in Slovenia, covering both pharmacies and connections to associations as well as doctors. The focus will be on the Arthritis Gel and Pain Patch as the first launch followed by Psoriasis Gel and Nasal Spray Night later this year.

The order corresponds to DKK 0,9 million in revenue which will be distributed over a 3.5-year period. A breakdown of the annual order allocation is disclosed below.

2022:   3,200 units

2023:   3,500 units

2023:   3,600 units

2024: 10,400 units

CS MEDICA’s products will be introduced to the Slovenian market later, after this summer.
This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 28-06-2022 08:05 CET.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.